CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Hunter Syndrome Mps Ii

Hunter Syndrome, also known as MPS II, is a rare genetic disorder that affects the body's ability to break down and recycle a specific type of sugar molecule. This leads to a buildup of these molecules in the body's cells and tissues, causing a range of symptoms that can vary in severity. Symptoms can include developmental delays, joint stiffness, heart problems, and cognitive impairment.

Entire World
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 609.945.0101

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information

Trademark Disclaimer

WCG’s Clinical Trial Listing Service (CTLS) is an online database of clinical research studies curated from public and proprietary sources.

Any references to third-party entities, companies, brands, trademarks, service marks, or logos are provided solely for informational purposes. Such references do not imply any endorsement, sponsorship, authorization, recommendation, partnership, or other affiliation between WCG and any such third party.